Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

Antibody deficiency is the most frequently encountered primary immunodeficiency disease (PIDD) and patients who lack the ability to make functional immunoglobulin require life-long replacement therapy to prevent serious bacterial infections. Human serum immunoglobulin manufactured from pools of dona...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Skoda-Smith, Suzanne, Torgerson, Troy R, Ochs, Hans D
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2010
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2817783/
https://ncbi.nlm.nih.gov/pubmed/20169031
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki